News
Partners in Beijing
Bayer HealthCare and Tsinghua University in Beijing, China, have signed a comprehensive collaboration agreement to enter into a strategic partnership. The two partners will establish a joint research center at Tsinghua University, the Bayer-Tsinghua (Institute of Biomedicine) Research Center of Innovative Drug Discovery.
The center is part of an initiative of Bayer HealthCare’s newly inaugurated R&D Center in Beijing. Under the terms of the agreement, scientists from the university will collaborate with scientists from Bayer Schering Pharma (BSP) along the drug discovery and development value chain, particularly in BSP’s therapeutic research areas of oncology, women’s healthcare, diagnostic imaging, and cardiology. “Complementing our own capabilities, strategic alliances with international innovation partners from academia are an essential element of our R&D strategy,” said Professor Andreas Busch, the member of the Board of Management of Bayer Schering Pharma responsible for Global Drug Discovery.
The center is part of an initiative of Bayer HealthCare’s newly inaugurated R&D Center in Beijing. Under the terms of the agreement, scientists from the university will collaborate with scientists from Bayer Schering Pharma (BSP) along the drug discovery and development value chain, particularly in BSP’s therapeutic research areas of oncology, women’s healthcare, diagnostic imaging, and cardiology. “Complementing our own capabilities, strategic alliances with international innovation partners from academia are an essential element of our R&D strategy,” said Professor Andreas Busch, the member of the Board of Management of Bayer Schering Pharma responsible for Global Drug Discovery.

Overview of Sales, Earnings and Financial Position
Partners in Beijing
Bayer Links
Investor Relations

Bookmark this page
E-mail this page
Advanced Search


